CCL3 presented significant differences between patients with AR and healthy controls. We have shown that the measurement of the levels of CCL3 in blood samples might represent an alternative approach of evaluating chemokines in allergic rhinitis in a non-academic outpatient facility when nasal collection of probes is not feasible. This evidence concerns the gene CCL3 and allergic rhinitis.